Literature DB >> 2546847

G proteins control diverse pathways of transmembrane signaling.

M Freissmuth1, P J Casey, A G Gilman.   

Abstract

Hormones, neurotransmitters, and autacoids interact with specific receptors and thereby trigger a series of molecular events that ultimately produce their biological effects. These receptors, localized in the plasma membrane, carry binding sites for ligands as diverse as peptides (e.g., glucagon, neuropeptides), lipids (e.g., prostaglandins), nucleosides and nucleotides (e.g., adenosine), and amines (e.g., catecholamines, serotonin). These receptors do not interest directly with their respective downstream effector (i.e., an ion channel and/or an enzyme that synthesizes a second messenger); rather, they control one or several target systems via the activation of an intermediary guanine nucleotide-binding regulatory protein or G protein. G proteins serve as signal transducers, linking extracellularly oriented receptors to membrane-bound effectors. Traffic in these pathways is regulated by a GTP (on)-GDP (off) switch, which is regulated by the receptor. The combination of classical biochemistry and recombinant DNA technology has resulted in the discovery of many members of the G protein family. These approaches, complemented in particular by electrophysiological experiments, have also identified several effectors that are regulated by G proteins. We can safely assume that current lists of G proteins and the functions that they control are incomplete.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2546847

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  81 in total

1.  Involvement of Gialpha2 in sodium butyrate-induced erythroblastic differentiation of K562 cells.

Authors:  M G Davis; Y Kawai; I J Arinze
Journal:  Biochem J       Date:  2000-03-01       Impact factor: 3.857

2.  Expression of the Arabidopsis G-protein GP alpha1: purification and characterisation of the recombinant protein.

Authors:  A Wise; P G Thomas; T H Carr; G A Murphy; P A Millner
Journal:  Plant Mol Biol       Date:  1997-03       Impact factor: 4.076

Review 3.  The closing and opening of TRPC channels by Homer1 and STIM1.

Authors:  J P Yuan; K P Lee; J H Hong; S Muallem
Journal:  Acta Physiol (Oxf)       Date:  2011-05-27       Impact factor: 6.311

4.  Ethanol increases receptor-dependent cyclic AMP production in cultured hepatocytes by decreasing G(i)-mediated inhibition.

Authors:  L E Nagy; S E DeSilva
Journal:  Biochem J       Date:  1992-09-15       Impact factor: 3.857

5.  Gi3 does not contribute to the inhibition of adenylate cyclase when stimulation of an alpha 2-adrenergic receptor causes activation of both Gi2 and Gi3.

Authors:  S J McClue; E Selzer; M Freissmuth; G Milligan
Journal:  Biochem J       Date:  1992-06-01       Impact factor: 3.857

6.  Characterization of the cDNA and genomic sequence of a G protein gamma subunit (gamma 5).

Authors:  K J Fisher; N N Aronson
Journal:  Mol Cell Biol       Date:  1992-04       Impact factor: 4.272

7.  Levels of G-proteins in liver and brain of lean and obese (ob/ob) mice.

Authors:  N McFarlane-Anderson; J Bailly; N Bégin-Heick
Journal:  Biochem J       Date:  1992-02-15       Impact factor: 3.857

Review 8.  Cell-matrix interactions during tumor invasion.

Authors:  J R Starkey
Journal:  Cancer Metastasis Rev       Date:  1990-09       Impact factor: 9.264

9.  Novel GNB1 mutations disrupt assembly and function of G protein heterotrimers and cause global developmental delay in humans.

Authors:  Katja Lohmann; Ikuo Masuho; Dipak N Patil; Hauke Baumann; Eva Hebert; Sofia Steinrücke; Daniel Trujillano; Nickolas K Skamangas; Valerija Dobricic; Irina Hüning; Gabriele Gillessen-Kaesbach; Ana Westenberger; Dusanka Savic-Pavicevic; Alexander Münchau; Gabriela Oprea; Christine Klein; Arndt Rolfs; Kirill A Martemyanov
Journal:  Hum Mol Genet       Date:  2017-03-15       Impact factor: 6.150

10.  Alpha 1-adrenoceptor-mediated inhibition of cellular cAMP accumulation in neonatal rat ventricular myocytes.

Authors:  S Barrett; N Honbo; J S Karliner
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-04       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.